Medicaid Patients Get Worse Cancer Care: Studies
By Dennis Thompson
Those covered by Medicaid, the federal health plan for low-income people, are less likely to have their cancer caught at an earlier, more treatable phase. Medicaid patients also are more likely to die from cancer than people with private insurance, researchers found.
Many factors likely contribute to this, including the fact that Medicaid patients often aren't experienced in navigating the health care system, said Dr. Jyoti Patel, an oncologist at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago.
"Research has shown that we can screen more patients, but that they get dropped along the way to treatment. We don't give them full access into curative therapy," said Patel, who's also a spokeswoman for the American Society of Clinical Oncology. "We need to do a better job to make sure that people who aren't savvy or can't advocate for themselves have that helping hand."
The three studies each focused on a different type of cancer and how insurance affects screening or care for patients. They all were presented this week at the American Society of Clinical Oncology annual meeting in Chicago.
The first involved Hodgkin lymphoma, with researchers from the University of Tennessee, Memphis, reviewing data for 6,395 patients treated for the cancer between 2007 and 2010.
Doctors were more likely to catch the person's lymphoma at an earlier stage if they had private insurance. About 59 percent of people with private insurance received a diagnosis before cancer had a chance to spread throughout their body, compared with 50 percent of Medicaid patients.
Medicaid patients were less likely to receive radiation treatment with just 35 percent undergoing the therapy, compared with 43 percent of privately insured patients.
And finally, privately insured patients were more likely to survive, with 84 percent surviving their lymphoma compared with 71 percent of Medicaid patients.
Results from the second study, which involved cases of melanoma, were similar.